Jardiance
- Product NDC
- 0597-0152
- Requested package NDC
- 0597-0152-70
- 11-digit product format
- 005970152
- Labeler code
- 0597
- Product ID
- 0597-0152_09daa78d-f417-436c-a29e-029c015ca6d6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Empagliflozin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Application
- NDA204629
- Marketing category
- NDA
- Marketing start
- 2014-08-01
- Substance
- EMPAGLIFLOZIN
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0597-0152 | 0597-0152-70 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204629-001 | JARDIANCE | EMPAGLIFLOZIN | 10MG | TABLET / ORAL | RLD | 2014-08-01 | |
| N204629-002 | JARDIANCE | EMPAGLIFLOZIN | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204629-001 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2014-08-15 | |
| N204629-001 | 7713938*PED | 2027-10-15 | Pediatric extension | ||
| N204629-001 | 7579449 | 2028-08-01 | Drug substance | 2014-08-15 | |
| N204629-001 | 7579449*PED | 2029-02-01 | Pediatric extension | ||
| N204629-001 | 8551957 | 2029-10-14 | U-1651 | 2016-03-14 | |
| N204629-001 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | |
| N204629-001 | 8551957*PED | 2030-04-14 | Pediatric extension | ||
| N204629-001 | 12115179*PED | 2030-08-11 | Pediatric extension | ||
| N204629-001 | 12527810 | 2033-04-22 | U-4403 | 2026-02-10 | |
| N204629-001 | 12527810*PED | 2033-10-22 | Pediatric extension | ||
| N204629-001 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | |
| N204629-001 | 11090323 | 2034-04-03 | U-3191 | 2021-08-20 | |
| N204629-001 | 11666590 | 2034-04-03 | U-3691 | 2023-10-03 | |
| N204629-001 | 11813275 | 2034-04-03 | U-3759 | 2023-12-13 | |
| N204629-001 | 11813275 | 2034-04-03 | U-3760 | 2023-12-13 | |
| N204629-001 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | |
| N204629-001 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | |
| N204629-001 | 12263153 | 2034-04-03 | U-4171 | 2025-04-29 | |
| N204629-001 | 12427162 | 2034-04-03 | U-4287 | 2025-10-17 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4293 | 2025-10-30 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4294 | 2025-10-30 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4295 | 2025-10-30 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4296 | 2025-10-30 | |
| N204629-001 | 12433906 | 2034-04-03 | U-4304 | 2025-10-30 | |
| N204629-001 | 9949997 | 2034-05-17 | U-2292 | 2018-05-15 | |
| N204629-001 | 9949997 | 2034-05-17 | U-3199 | 2018-05-15 | |
| N204629-001 | 9949997 | 2034-05-17 | U-3325 | 2018-05-15 | |
| N204629-001 | 9949998 | 2034-06-11 | U-2290 | 2018-05-15 | |
| N204629-001 | 10258637*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 11090323*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 11813275*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 11833166*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 12433906*PED | 2034-10-03 | Pediatric extension | ||
| N204629-001 | 9949997*PED | 2034-11-17 | Pediatric extension | ||
| N204629-001 | 9949998*PED | 2034-12-11 | Pediatric extension | ||
| N204629-002 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2014-08-15 | |
| N204629-002 | 7713938*PED | 2027-10-15 | Pediatric extension | ||
| N204629-002 | 7579449 | 2028-08-01 | Drug substance | 2014-08-15 | |
| N204629-002 | 7579449*PED | 2029-02-01 | Pediatric extension | ||
| N204629-002 | 8551957 | 2029-10-14 | U-1651 | 2016-03-14 | |
| N204629-002 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | |
| N204629-002 | 8551957*PED | 2030-04-14 | Pediatric extension | ||
| N204629-002 | 12115179*PED | 2030-08-11 | Pediatric extension | ||
| N204629-002 | 12527810 | 2033-04-22 | U-4403 | 2026-02-10 | |
| N204629-002 | 12527810*PED | 2033-10-22 | Pediatric extension | ||
| N204629-002 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | |
| N204629-002 | 11090323 | 2034-04-03 | U-3191 | 2021-08-20 | |
| N204629-002 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | |
| N204629-002 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | |
| N204629-002 | 12263153 | 2034-04-03 | U-4171 | 2025-04-29 | |
| N204629-002 | 12427162 | 2034-04-03 | U-4287 | 2025-10-17 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4293 | 2025-10-30 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4294 | 2025-10-30 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4295 | 2025-10-30 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4296 | 2025-10-30 | |
| N204629-002 | 12433906 | 2034-04-03 | U-4304 | 2025-10-30 | |
| N204629-002 | 9949997 | 2034-05-17 | U-2292 | 2018-05-15 | |
| N204629-002 | 9949998 | 2034-06-11 | U-2290 | 2018-05-15 | |
| N204629-002 | 10258637*PED | 2034-10-03 | Pediatric extension | ||
| N204629-002 | 11090323*PED | 2034-10-03 | Pediatric extension | ||
| N204629-002 | 11833166*PED | 2034-10-03 | Pediatric extension | ||
| N204629-002 | 12433906*PED | 2034-10-03 | Pediatric extension | ||
| N204629-002 | 9949997*PED | 2034-11-17 | Pediatric extension | ||
| N204629-002 | 9949998*PED | 2034-12-11 | Pediatric extension |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N204629-001 | NPP | 2026-06-20 |
| N204629-001 | I-922 | 2026-09-21 |
| N204629-001 | PED | 2026-12-20 |
| N204629-002 | NPP | 2026-06-20 |
| N204629-002 | PED | 2026-12-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | JARDIANCE | 10MG | TABLET / ORAL | RLD | 2014-08-01 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-002 | JARDIANCE | 25MG | TABLET / ORAL | RLD, RS | 2014-08-01 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2014-08-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 7713938*PED | 2027-10-15 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 7579449 | 2028-08-01 | Drug substance | 2014-08-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 7579449*PED | 2029-02-01 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 8551957 | 2029-10-14 | U-1651 | 2016-03-14 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12115179 | 2030-02-11 | U-4023 | 2024-11-12 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 8551957*PED | 2030-04-14 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12115179*PED | 2030-08-11 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12527810 | 2033-04-22 | U-4403 | 2026-02-10 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12527810*PED | 2033-10-22 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 10258637 | 2034-04-03 | U-2290 | 2019-04-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 11090323 | 2034-04-03 | U-3191 | 2021-08-20 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 11666590 | 2034-04-03 | U-3691 | 2023-10-03 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 11813275 | 2034-04-03 | U-3759 | 2023-12-13 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 11813275 | 2034-04-03 | U-3760 | 2023-12-13 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 11833166 | 2034-04-03 | U-3776 | 2024-01-03 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 11833166 | 2034-04-03 | U-3777 | 2024-01-03 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12263153 | 2034-04-03 | U-4171 | 2025-04-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12427162 | 2034-04-03 | U-4287 | 2025-10-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12433906 | 2034-04-03 | U-4304 | 2025-10-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12433906 | 2034-04-03 | U-4293 | 2025-10-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12433906 | 2034-04-03 | U-4294 | 2025-10-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12433906 | 2034-04-03 | U-4295 | 2025-10-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12433906 | 2034-04-03 | U-4296 | 2025-10-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 9949997 | 2034-05-17 | U-2292 | 2018-05-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 9949997 | 2034-05-17 | U-3325 | 2018-05-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 9949997 | 2034-05-17 | U-3199 | 2018-05-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 9949998 | 2034-06-11 | U-2290 | 2018-05-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 10258637*PED | 2034-10-03 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 11090323*PED | 2034-10-03 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 11813275*PED | 2034-10-03 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 11833166*PED | 2034-10-03 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 12433906*PED | 2034-10-03 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 9949997*PED | 2034-11-17 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | 9949998*PED | 2034-12-11 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-002 | 7713938 | 2027-04-15 | Drug substance, Drug product | 2014-08-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-002 | 7713938*PED | 2027-10-15 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-002 | 7579449 | 2028-08-01 | Drug substance | 2014-08-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N204629-002 | 7579449*PED | 2029-02-01 | Pediatric extension | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | N204629-002 | 8551957 | 2029-10-14 | U-1651 | 2016-03-14 | a50c72e98297… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | NPP | 2026-06-20 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | I-922 | 2026-09-21 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N204629-001 | PED | 2026-12-20 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N204629-002 | NPP | 2026-06-20 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N204629-002 | PED | 2026-12-20 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jardiance | EMPAGLIFLOZIN | Aphena Pharma Solutions - Tennessee, LLC | 334f1b3d-5670-6685-e063-6294a90a7e47 | 2026-06-17 | Warnings, Adverse reactions | 204629 NDA204629 |
| Jardiance | EMPAGLIFLOZIN | Cardinal Health 107, LLC | 5777b8a8-ada6-4950-8548-43a1de11f075 | 2026-02-17 | Warnings, Adverse reactions | 204629 NDA204629 |
| Jardiance | EMPAGLIFLOZIN | Boehringer Ingelheim Pharmaceuticals, Inc. | faf3dd6a-9cd0-39c2-0d2e-232cb3f67565 | 2026-01-30 | Warnings, Adverse reactions | 204629 NDA204629 0597-0152-70 0597-0152 00597015270 |
| Jardiance | EMPAGLIFLOZIN | Aphena Pharma Solutions - Tennessee, LLC | 8b6261f6-4bdc-462e-8af1-4064664c62f3 | 2025-10-27 | Warnings, Adverse reactions | 204629 NDA204629 |
| Jardiance | EMPAGLIFLOZIN | A-S Medication Solutions | a77214ca-572e-485e-aae9-f7950187e5fb | 2023-08-08 | Warnings, Adverse reactions | 204629 NDA204629 |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | 942a82a4-cbbd-4e44-9965-8d03f767912b | 2023-07-24 | Warnings, Adverse reactions | 204629 NDA204629 |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | 1782b947-4a72-4feb-a488-1469d9af82bd | 2023-05-03 | Warnings, Adverse reactions | 204629 NDA204629 |
| JARDIANCE | EMPAGLIFLOZIN | A-S Medication Solutions | f2b41c77-0abb-40ee-8578-86a748d0e19e | 2023-05-03 | Warnings, Adverse reactions | 204629 NDA204629 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Jardiance
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| EMPAGLIFLOZIN | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| HDC1R2M35U | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| faf3dd6a-9cd0-39c2-0d2e-232cb3f67565 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3a90349e-ff2e-41bd-a106-b368fbc1c1f8 | Product name | 1 | 20200612 |
| e2382c7e-9e14-4196-aeff-98e2cfaf63cb | Product name | 1 | 20170224 |
| a1e505bd-ab91-46e4-b7bc-a43a10199330 | Product name | 2 | 20170214 |
| 2988466d-5fc4-4430-9cee-fc9132f02d2c | Product name | 1 | 20150910 |
| 24acbc89-fd6a-458c-aa62-a3485b119bed | Product name | 1 | 20150323 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0597-0152-07 | Jardiance | 7 in 1 BOTTLE | TABLET, FILM COATED | 7 | 31 | |
| 0597-0152-07 | Jardiance | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 31 | |
| 0597-0152-30 | Jardiance | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 31 | |
| 0597-0152-37 | Jardiance | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 31 | |
| 0597-0152-37 | Jardiance | 30 in 1 CARTON | TABLET, FILM COATED | 30 | 31 | |
| 0597-0152-70 | Jardiance | 7 in 1 CARTON | TABLET, FILM COATED | 7 | 31 | |
| 0597-0152-70 | Jardiance | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 31 | |
| 0597-0152-90 | Jardiance | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 31 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0597-0152-07 | EA - Each | 0597-0152 | 21a247ea-12da-494b-be59-8dfc1ba136ad | 1 | 2022-06-06 |
| 0597-0152-30 | EA - Each | 0597-0152 | 34ba6f63-aef1-4cbe-8915-4f6a394e9580 | 1 | 2014-09-03 |
| 0597-0152-37 | EA - Each | 0597-0152 | 42255d9c-5c76-4039-ab38-7705119f54e2 | 1 | 2015-10-02 |
| 0597-0152-90 | EA - Each | 0597-0152 | 72d8dab7-3bad-4b95-b22b-c8d5edb2073c | 1 | 2014-09-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| empagliflozin | ACTIVE INGREDIENT | HDC1R2M35U | JARDIANCE (EMPAGLIFLOZIN) TABLET, FILM COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | 2 | |
| empagliflozin | ACTIVE MOIETY | HDC1R2M35U | JARDIANCE (EMPAGLIFLOZIN) TABLET, FILM COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.] | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0597-0152-70 | 00597015270 | 7 BLISTER PACK in 1 CARTON (0597-0152-70) > 1 TABLET, FILM COATED in 1 BLISTER PACK | 7 blister pack | 2014-08-01 | 0000-00-00 | No | No | Current |